Sam Levin is a biotech entrepreneur and accomplished scientific leader with 15 years of research experience and over a decade of leading complex, multidisciplinary scientific enterprises. He has deep expertise at the intersection of genetic engineering, automation, and complex systems biology. He has numerous peer-reviewed publications in leading journals and serves as an advisor to multiple companies and research organizations. His work has been featured in top outlets including The New York Times, Forbes, and the Discovery Channel. Prior to Neion Bio, Sam was the Co-Founder and CEO of Melonfrost, where he built the world’s most high-throughput automated bioreactor system, integrated with proprietary machine learning algorithms to direct microbial evolution for industrial biotechnology. Sam holds a PhD and Bachelor’s Degree in the field of evolutionary biology from the University of Oxford.